0001683168-20-000155.txt : 20200115 0001683168-20-000155.hdr.sgml : 20200115 20200115191002 ACCESSION NUMBER: 0001683168-20-000155 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200113 FILED AS OF DATE: 20200115 DATE AS OF CHANGE: 20200115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GROVES JASON L CENTRAL INDEX KEY: 0001480679 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 20529220 MAIL ADDRESS: STREET 1: C/O MEDIFAST, INC. STREET 2: 3600 CRONDALL LANE CITY: OWINGS MILLS STATE: MD ZIP: 21117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P.O. BOX 130235 CITY: ANN ARBOR STATE: MI ZIP: 48113 BUSINESS PHONE: 734-245-1700 MAIL ADDRESS: STREET 1: P.O. BOX 130235 CITY: ANN ARBOR STATE: MI ZIP: 48113 FORMER COMPANY: FORMER CONFORMED NAME: Gemphire Therapeutics Inc. DATE OF NAME CHANGE: 20150331 4 1 ownership.xml X0306 4 2020-01-13 0 0001638287 NeuroBo Pharmaceuticals, Inc. NRBO 0001480679 GROVES JASON L C/O NEUROBO PHARMACEUTICALS, INC. 177 HUNTINGTON AVENUE, SUITE 1700 BOSTON MA 02115 1 0 0 0 Non-qualified stock option (right to buy) 8.39 2020-01-13 4 A 0 60000 0 A 2030-01-12 Common Stock 60000 60000 D The option vests in 36 equal monthly installments beginning on 2/13/2020, such that the option will be fully vested on the third anniversary of the date of grant. Exhibit 24.1 - Power of Attorney /s/ Richard Kang, attorney-in-fact 2020-01-15 EX-24 2 grovespoa.htm POWER OF ATTORNEY

Exhibit 24

 

POWER OF ATTORNEY

 

Know all by these present, that the undersigned hereby constitutes and appoints each of Jeong Gu (Richard) Kang and Amy Rabourn, signing singly, with full power of substitution, the undersigned's true and lawful attorney-in-fact to:

 

(1)execute for and on behalf of the undersigned, forms and authentication documents for EDGAR Filing Access;

 

(2)do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such forms and authentication documents;

 

(3)execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director and/or 10% shareholder of NeuroBo Pharmaceuticals, Inc. (the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a), and Schedules 13D and 13G in accordance with Section 13, of the Securities Exchange Act of 1934 and the rules thereunder;

 

(4)do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and Schedules 13D and 13G and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

 

(5)take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interests of, or legally required by the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 and Schedules 13D and 13G with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed 2nd day of January 2020.

 

/s/ Jason L. Groves
Signature

 

 

Jason L. Groves
Print Name